Reference
Das B, et al. Alemtuzumab (Campath-1H) therapy for refractory rejections in pediatric heart transplant recipients. Pediatric Transplantation 21: e12844, No. 1, Feb 2017. Available from: URL: http://doi.org/10.1111/petr.12844 - USA
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1648, 24 (2017). https://doi.org/10.1007/s40278-017-29003-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-29003-2